FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely cilazapril (as cilazapril monohydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cilazapril (as cilazapril monohydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Levothyroxine sodium anhydrous 150 microgram oral capsule Count of base of active ingredient False 1 Inferred relationship Some
    Levothyroxine sodium anhydrous 150 microgram oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely lapatinib (as lapatinib ditosylate) 250 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely lapatinib (as lapatinib ditosylate) 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Darunavir (as darunavir ethanolate) 600 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Darunavir (as darunavir ethanolate) 600 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Levothyroxine sodium anhydrous 50 microgram oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Levothyroxine sodium anhydrous 50 microgram oral capsule Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely darunavir (as darunavir ethanolate) 300 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely darunavir (as darunavir ethanolate) 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing only tagraxofusp in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Fenoprofen (as fenoprofen calcium) 300 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Fenoprofen (as fenoprofen calcium) 300 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Levothyroxine sodium anhydrous 50 microgram oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Levothyroxine sodium anhydrous 50 microgram oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Flucloxacillin (as flucloxacillin sodium) 250 mg oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Flucloxacillin (as flucloxacillin sodium) 250 mg oral capsule Count of base of active ingredient False 1 Inferred relationship Some
    Imatinib (as imatinib mesilate) 400 mg oral capsule Count of base of active ingredient False 1 Inferred relationship Some
    Imatinib (as imatinib mesilate) 400 mg oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cilazapril (as cilazapril monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cilazapril (as cilazapril monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 15 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely levothyroxine sodium anhydrous 75 microgram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely levothyroxine sodium anhydrous 75 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Levothyroxine sodium anhydrous 100 microgram oral capsule Count of base of active ingredient False 1 Inferred relationship Some
    Levothyroxine sodium anhydrous 100 microgram oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing only andexanet alfa (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only calaspargase pegol in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Rifamycin only product Count of base of active ingredient False 1 Inferred relationship Some
    Calaspargase pegol only product Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only rifamycin in oral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only andexanet alfa in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only barium sulfate (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Cyanocobalamin (57-Co) only product in oral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Iodohippurate (123-I) sodium only product Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only norcholestenol iodomethyl (131-I) (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Chromic phosphate (32-P) only product in parenteral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only sodium iodide (131-I) (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Norcholestenol iodomethyl (131-I) only product in parenteral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Sodium iodide (131-I) only product in parenteral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Iothalamic acid only product Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only iodohippurate (123-I) sodium in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Hydroxyapatite only product Count of base of active ingredient False 1 Inferred relationship Some
    Iodinated (125-I) human serum albumin only product Count of base of active ingredient False 1 Inferred relationship Some
    Sodium iodide (131-I) only product in oral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Hydroxyapatite only product in parenteral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only indigotindisulfonate sodium in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only iodinated (125-I) human serum albumin in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Mangafodipir only product Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only indigotindisulfonate sodium (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Cyanocobalamin (58-Co) only product Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only cyanocobalamin (57-Co) (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only mangafodipir in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only cyanocobalamin (58-Co) in oral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only chromic phosphate (32-P) (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pemirolast potassium 1 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely pemirolast potassium 1 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pemirolast potassium 1 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 3
    Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely tramadol hydrochloride 50 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely tramadol hydrochloride 50 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Aspirin 81 mg chewable tablet Count of base of active ingredient False 1 Inferred relationship Some
    Aspirin 81 mg chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet Has presentation strength numerator value False 1 Inferred relationship Some 1
    Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Ropinirole (as ropinirole hydrochloride) 8 mg prolonged-release oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Ropinirole (as ropinirole hydrochloride) 8 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Paracetamol 80 mg chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Paracetamol 80 mg chewable tablet Count of base of active ingredient False 1 Inferred relationship Some
    Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 3
    Product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Prednisolone acetate 1.25 mg/mL eye suspension Count of base of active ingredient False 1 Inferred relationship Some
    Prednisolone acetate 1.25 mg/mL eye suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely valproic acid 125 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely valproic acid 125 milligram/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Zolmitriptan 5 mg orodispersible tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Zolmitriptan 5 mg orodispersible tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some

    Start Previous Page 169 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start